Compounds > trimethoprim--sulfamethoxazole-drug-combination

trimethoprim--sulfamethoxazole-drug-combination and Candidiasis--Vulvovaginal

trimethoprim--sulfamethoxazole-drug-combination has been researched along with Candidiasis--Vulvovaginal* in 1 studies

Other Studies

1 other study(ies) available for trimethoprim--sulfamethoxazole-drug-combination and Candidiasis--Vulvovaginal

ArticleYear
Single-dose therapy for genitourinary infections.
    American family physician, 1987, Volume: 36, Issue:6

    Single-dose therapy for selected genitourinary tract infections is an effective alternative to multiple-dose regimens. Candidal vulvovaginitis and trichomonal vaginitis may be routinely treated with single-dose regimens. With acute cystitis, candidates for single-dose therapy include patients who have a short duration of symptoms and are likely to comply with follow-up.

    Topics: Acute Disease; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Cystitis; Drug Administration Schedule; Drug Combinations; Female; Gardnerella vaginalis; Haemophilus Infections; Humans; Infections; Metronidazole; Sulfamethoxazole; Trichomonas Vaginitis; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vaginal Diseases

1987